Supplemental material
Leukemia & Lymphoma
Volume 58, 2017 - Issue 12
Original Articles: Clinical
Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus
, , , , , , , 
, , , , , , , , , , , & show all
Cristina JoaoInstitutto Português de Oncologia de Lisboa, Portugal and Champalimaud Centre for the Unknown, Hematology, Lisbon, Portugal; http://orcid.org/0000-0002-3978-766XView further author information
http://orcid.org/0000-0002-3978-766XView further author information, , , , , , , , , , , & show allReprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related Research Data
The Development and Validation of a Measure of Health-Related Quality of Life for Non-Hodgkin’s Lymphoma: The Functional Assessment of Cancer Therapy—Lymphoma (FACT-Lym)
Source:
Hindawi Limited
Toxicity and response criteria of the Eastern Cooperative Oncology Group
Source:
Ovid Technologies (Wolters Kluwer Health)
Erratum to: Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer
Source:
Springer Nature
Quality of life assessment in women with breast cancer: benefits, acceptability and utilization
Source:
Springer Science and Business Media LLC
Validation of the Chinese EORTC chronic lymphocytic leukaemia module - application of classical test theory and item response theory.
Source:
Springer Science and Business Media LLC
The Functional Assessment of Cancer Therapy - General (FACT-G) is valid for monitoring quality of life in patients with non-Hodgkin lymphoma
Source:
Informa UK Limited
Ibrutinib for the treatment of mantle cell lymphoma.
Source:
Informa UK Limited
Achieving optimal response at 12 months is associated with a better health-related quality of life in patients with chronic myeloid leukemia: a prospective, longitudinal, single center study.
Source:
Springer Science and Business Media LLC
Measuring health-related quality of life in leukemia: The functional assessment of cancer therapy - Leukemia (FACT-Leu) questionnaire
Source:
International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.
Linking provided by
